Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 24.75
-1.90 (-7.13%)
May 4, 2026, 5:29 PM CET
Xspray Pharma AB Revenue
Xspray Pharma AB had revenue of 557.00K SEK in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 1.10M, down -42.72% year-over-year. In the year 2025, Xspray Pharma AB had annual revenue of 2.47M.
Revenue (ttm)
1.10M
Revenue Growth
-42.72%
P/S Ratio
938.35
Revenue / Employee
42.35K
Employees
26
Market Cap
1.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.47M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Saniona AB | 434.40M |
| Cantargia AB | 316.70M |
| BioInvent International AB | 217.86M |
| Genovis AB (publ.) | 133.84M |
| Oncopeptides AB | 71.12M |
| Egetis Therapeutics AB | 63.10M |
| Medivir AB | 8.51M |
| Flerie AB | 1.80M |
Xspray Pharma AB News
- 2 years ago - Xspray Pharma AB Transcript: Status Update - Transcripts
- 5 years ago - Xspray Pharma AB Transcript: Pareto Securities’ Annual Healthcare Conference 2021 - Transcripts